Chinese Medical E-ournals Database
Adv Search
中华妇幼临床医学杂志(电子版)

Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition) ›› 2026, Vol. 22 ›› Issue (02): 93 -102. doi: 10.3877/cma.j.issn.1673-5250.2026.02.001

Forum

Current research status on mechanism of immune factors in occurrence and development of neonatal necrotizing enterocolitis

Xia Li1,2, Shiping Li1, Yi Qu1,†()   

  1. 1Department of Neonatology, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China
    2Department of Neonatology, Luzhou Maternal and Child Health Hospital (Luzhou Second People′s Hospital), Luzhou 646000, Sichuan Province, China
  • Received:2025-10-01 Revised:2026-01-21 Published:2026-04-01
  • Corresponding author: Yi Qu
  • Supported by:
    National Natural Science Foundation of China(82371717); Project of Science and Technology Department of Sichuan Province(2024NSFSC0047)
HTML ( ) PDF ( )

Neonatal necrotizing enterocolitis (NEC) is a severe acute inflammatory bowel disease with a complex pathogenesis involving various perinatal factors. Among them, the interaction between the neonatal immune system and intestinal microecology (IM) significantly affects the pathological development of neonatal NEC. This article summarizes the roles of neonatal immune cell subpopulations, immune molecules, immune regulatory factors, and gut microbiota (GM) in neonatal NEC, focusing on the mechanisms by which immune and GM dysregulation leads to intestinal barrier damage and inflammatory responses, and emphasizes the potential of immune regulation and GM intervention strategies in the prevention and treatment of neonatal NEC. The aim is to systematically summarize the research findings in this field to provide references for promoting the development of immune-microbiota therapy for neonatal NEC.

Key words: Enterocolitis, necrotizing, Immunity, maternally-acquired, Gastrointestinal microbiome, Immunomodulation, Immunotherapy, Infant, newborn, diseases, Intestinal barrier
表1 益生菌在NEC治疗中的作用机制
文献(第1作者，发表年) 益生菌的作用 作用机制 研究类型 证据等级(OCEBM2011)
Aveline[72]，2026 竞争性作用 排斥病原菌，抑制病原体的附着和定植，降低感染风险 倾向性匹配研究 3级
Abdullahi[30]，2025 增强肠道屏障功能 促进黏膜免疫的建立，增加抗菌肽和免疫球蛋白的合成，隔绝肠道病菌，提高宿主抵抗力，减少感染风险 荟萃分析 1级
Kalantar[31]，2025 调节免疫细胞功能 促进DC成熟，增强T细胞的应答反应，影响细胞因子分泌，保持免疫系统平衡 荟萃分析 1级
Dai[70]，2025 改善肠道微生物群 乳酸杆菌与双歧杆菌均可通过改善新生儿肠道微生物群、增强肠道屏障功能、调节免疫反应降低NEC发生率，二者联合使用时效果更为显著 荟萃分析 1级
Pan[32]，2024 促进短链脂肪酸生成 某些乳酸杆菌通过调节小肠微生物群，促进短链脂肪酸的生成，从而增强免疫耐受 动物实验 5级
图1 免疫-微生物轴在新生儿NEC中的作用机制及靶向干预策略示意图注：NEC为新生儿坏死性小肠结肠炎。GM为肠道微生物群。Treg为调节性T细胞，Th为辅助性T细胞。STAT为信号转导和激活因子，GATA3为一种转录因子，INF-γ为γ干扰素，IL为白细胞介素，TNF-α为肿瘤坏死因子-α，TGF-β为转化生长因子-β
[1]
Alganabi M, Biouss G, Ganji N, et al.Remote ischemic conditioning causes CD4 T cells shift towards reduced cell-mediated inflammation[J]. Pediatr Surg Int, 2022, 38(5): 657-664. DOI: 10.1007/s00383-022-05093-3.
[2]
Han X, Hou YT, Chen TY, et al. The glutamine metabolic switch influences the response of neonatal intestinal macrophages to breast milk[J]. Cell Mol Gastroenterol Hepatol, 2025, 20(3): 101683. DOI: 10.1016/j.jcmgh.2025.101683.
[3]
Lin YG, Xie Z, Li ZY, et al. The microbiota-gut-brain axis: acrucial immunomodulatory pathway for Bifidobacterium animalis subsp. lactis′ resilience against LPS treatment in neonatal rats[J]. Int J Biol Macromol, 2024, 266(P2): 131255. DOI: 10.1016/j.ijbiomac.2024.131255.
[4]
Russell JT, Lauren RJ, Cruz D, et al. Antibiotics and the developing intestinal microbiome, metabolome and inflammatory environment in a randomized trial of preterm infants[J]. Sci Rep, 2021, 11(1): 1943. DOI: 10.1038/S41598-021-80982-6.
[5]
Gala AAD, Kumar H, Sedani S, et al. Alterations in the stool microbiome in newborns undergoing mild therapeutic hypothermia after hypoxic-ischemic encephalopathy[J]. Dev Neurosci, 2022, 44(4-5): 373-383. DOI: 10.1159/000522523.
[6]
Gopalakrishna KP, Macadangdang BR, Rogers MB, et al. Maternal IgA protects against the development of necrotizing enterocolitis in preterm infants[J]. Nat Med, 2019, 25(7): 1110-1115. DOI: 10.1038/s41591-019-0480-9.
[7]
Feng X, Li JZ, Meng YW, et al. Vitamin D deficiency exacerbates d-galactose-induced intestinal barrier dysfunction in a murine model of intestinal aging[J]. J Agric Food Chem, 2025, 73(39): 24725-24740. DOI: 10.1021/acs.jafc.5c07085.
[8]
Dirks J, Fortmann I, Marißen J, et al. Effect of gestational age on lymphocyte phenotypes in hospitalized preterm infants[J]. J Allergy Clin Immunol, 2025, 157(2): 506-516. DOI: 10.1016/j.jaci.2025.09.030.
[9]
Pacella I, Chiara DM, Prota R, et al. Reduction in regulatory T cells in preterm newborns is associated with necrotizing enterocolitis[J]. Pediatr Res, 2023, 94(5): 1789-1796. DOI: 10.1038/S41390-023-02658-3.
[10]
Jong DR, Tenbrock K, Ohl K. New insights in immunometabolism in neonatal monocytes and macrophages in health and disease[J]. Int J Mol Sci, 2023, 24(18): 14173. DOI: 10.3390/ijms241814173.
[11]
Dikiy S, Rudensky AY. Principles of regulatory T cell function[J]. Immunity, 2023, 56(2): 240-255. DOI: 10.1016/j.immuni.2023.01.004.
[12]
Raheem A, Khan I, Ahmad I, et al. The emerging role of tissue regulatory T cells in tissue repair and regeneration[J]. Front Immunol, 2025, 16: 1640113. DOI: 10.3389/fimmu.2025.1640113.
[13]
Chen YY, Li H, Zhang YM, et al. BCG vaccination reprograms the function of M-MDSCs and aggravates necrotizing enterocolitis in neonates[J]. Immunology, 2025, 175(4): 501-517. DOI: 10.1111/imm.13946.
[14]
Davenport P, Sola-Visner M. Immunologic effects of red blood cell and platelet transfusions in neonates[J]. Curr Opin Hematol, 2022, 29(6): 297-305. DOI: 10.1097/MOH.0000000000000736.
[15]
Schreurs RRCE, Baumdick EM, Sagebiel FA, et al. Human fetal TNF-α-cytokine-producing CD4＋ effector memory T cells promote intestinal development and mediate inflammation early in life[J]. Immunity, 2019, 50(2): 462-476.e8. DOI: 10.1016/j.immuni.2018.12.010.
[16]
Lu L, Lu J, Yu YY, et al. Necrotizing enterocolitis intestinal barrier function protection by antenatal dexamethasone and surfactant-D in a rat model[J]. Pediatr Res, 2021, 90(4): 768-775. DOI: 10.1038/S41390-020-01334-0.
[17]
Li B, Yeganeh M, Lee D, et al. Exploring the complex pathophysiology of necrotizing enterocolitis in preterm neonates[J]. Annu Rev Pathol, 2026, 21(1): 37-58. DOI: 10.1146/annurev-pathmechdis-070224-014223.
[18]
Tumuhamye J, Sommerfelt H, Tumwine JK, et al. Umbilical cord stump infections in central uganda: incidence, bacteriological profile, and risk factors[J]. Int J Environ Res Public Health, 2022, 19(23): 16055-16055. DOI: 10.3390/ijerph192316055.
[19]
Dessie AM, Geremew H, Feleke SF, et al. Multilevel analysis of individual and community level factors associated with the application of cow dung and oil on the umbilical cord stump in Ethiopia[J]. Front Pediatr, 2022, 10：1044056. DOI: 10.3389/fped.2022.1044056.
[20]
Pavithra C, Shreya R, Akhil M, et al. Enteric nervous system in neonatal necrotizing enterocolitis[J]. Curr Pediatr Rev, 2021, 18(1): 9-24. DOI: 10.2174/1573396317666210908162745.
[21]
Ziaka M, Exadaktylos A. Gut-derived immune cells and the gut-lung axis in ARDS[J]. Crit Care, 2024, 28(1): 220. DOI: 10.1186/S13054-024-05006-X.
[22]
Willis KA, Ambalavanan N. Necrotizing enterocolitis and the gut-lung axis[J]. Semin Perinatol, 2021, 45(6): 151454. DOI: 10.1016/j.semperi.2021.151454.
[23]
Donald K, Serapio-Palacios A, Gerbec Z, et al. Secretory IgA in breast milk protects against asthma through modulation of the gut microbiota[J]. Cell Rep, 2024, 43(10): 114835. DOI: 10.1016/j.celrep.2024.114835.
[24]
León ED, Francino MP. Roles of secretory immunoglobulin A in host-microbiota interactions in the gut ecosystem[J]. Front Microbiol, 2022, 13: 880484. DOI: 10.3389/fmicb.2022.880484.
[25]
Dotinga BM, Bao M, Solberg R, et al. Gene expression in the intestine of newborn piglets after hypoxia-reoxygenation[J]. Pediatr Res, 2023, 94(4): 1365-1372. DOI: 10.1038/S41390-023-02657-4.
[26]
Bargheet A, Noordzij HT, Ponsero AJ, et al. Dynamics of gut resistome and mobilome in early life: a Meta-analysis[J]. EBioMedicine, 2025，114: 105630. DOI: 10.1016/j.ebiom.2025.105630.
[27]
Aires J, Ilhan EZ, Nicolas L, et al. Occurrence of neonatal necrotizing enterocolitis in premature neonates and gut microbiota: a case-control prospective multicenter study[J]. Microorganisms, 2023, 11(10): 2457. DOI: 10.3390/microorganisms11102457.
[28]
Singh DK, Miller CM, Orgel KA, et al. Necrotizing enterocolitis: bench to bedside approaches and advancing our understanding of disease pathogenesis[J]. Front Pediatr, 2023, 10: 1107404. DOI: 10.3389/fped.2022.1107404.
[29]
Chen YH, Gao KX, Chen N, et al. Identification of key mitochondria-related genes in necrotizing enterocolitis using single-cell hdWGCNA and experimental verification[J]. Pediatr Res, 2026: 1-12 [2026-01-21]. DOI: 10.1038/S41390-026-04779-X. [published online ahead of print January 19, 2026].
[30]
Abdullahi AM, Zhao S, Xu Y. Efficacy of probiotic supplementation in preventing necrotizing enterocolitis in preterm infants：a systematic review and Meta-analysis[J]. J Matern Fetal Neonatal Med, 2025, 38(1): 2485215. DOI: 10.1080/14767058.2025.2485215.
[31]
Kalantar HT, Galadari S, Kalantar AT, et al. Effect of probiotic supplementation in preventing necrotizing enterocolitis sepsis and mortality among preterm and very low birth weight infants：a systematic review and Meta-analysis[J]. Cureus, 2025, 17(10): e94762. DOI: 10.7759/cureus.94762.
[32]
Pan LL, Sun YD, Dong XL, et al. Infant feces-derived lactobacillus gasseri FWJL-4 mitigates experimental necrotizing enterocolitis via acetate production[J]. Gut Microbes, 2024, 16(1): 2430541. DOI: 10.1080/19490976.2024.2430541.
[33]
Zaikova E, Kaplina A, Belozertsev D, et al. An early post-birth immune-microbiota landscape predicts the development of necrotizing enterocolitis in term newborns with congenital heart defects[J]. Sci Rep, 2025, 15(1): 33811. DOI: 10.1038/S41598-025-02542-6.
[34]
Sanidad KZ, Rager SL, Carrow HC, et al. Gut bacteria-derived serotonin promotes immune tolerance in early life[J]. Sci Immunol, 2024, 9(93): eadj4775-eadj4775. DOI: 10.1126/sciimmunol.adj4775.
[35]
Spreckels JE, Zhernakova A. Milk and bugs educate infant immune systems[J]. Immunity, 2021, 54(8): 1633-1635. DOI: 10.1016/j.immuni.2021.07.013.
[36]
Robertson MK, Cermack K, Woodruff T, et al. Review: microbial metabolites-a key to address gut inflammation and barrier dysfunction in the premature infant[J]. Gut Microbes, 2025, 17(1): 2551117. DOI: 10.1080/19490976.2025.2551117.
[37]
Guo JL, Han X, Huang WD, et al. Gut dysbiosis during early life：causes，health outcomes，and amelioration via dietary intervention[J]. Crit Rev Food Sci Nutr, 2021, 62(26): 7199-7221. DOI: 10.1080/10408398.2021.1912706.
[38]
Oshima K, Hinoki A, Uchida H, et al. Single-cell RNA sequencing of intestinal immune cells in neonatal necrotizing enterocolitis[J]. Pediatr Surg Int, 2023, 39(1): 179. DOI: 10.1007/S00383-023-05461-7.
[39]
Olaloye OO, Liu P, Toothaker JM, et al. CD16＋CD163＋ monocytes traffic to sites of inflammation during necrotizing enterocolitis in premature infants[J]. J Exp Med, 2021, 218(9): e20200344. DOI: 10.1084/jem.20200344.
[40]
Egozi A, Olaloye O, Werner L, et al. Single-cell atlas of the human neonatal small intestine affected by necrotizing enterocolitis[J]. PLoS Biol, 2023, 21(5): e3002124. DOI: 10.1371/journal.pbio.3002124.
[41]
Zheng XQ, Lei W, Zhang YM, et al. Neuropilin-1high monocytes protect against neonatal inflammation[J]. Cell Mol Immunol, 2024, 21(6): 575-588. DOI: 10.1038/s41423-024-01157-7.
[42]
Ongena R, Vanrompay D, Cox E, et al. Uptake and nuclear translocation of lactoferrin by porcine monocytes: impact of iron binding, protease activity, and monocyte activation[J]. Biometals, 2025, 38(6): 1973-1989. DOI: 10.1007/s10534-025-00741-2.
[43]
Wei JQ, Meng ZL, Li ZY, et al. New insights into intestinal macrophages in necrotizing enterocolitis: the multi-functional role and promising therapeutic application[J]. Front Immunol, 2023, 14: 1261010. DOI: 10.3389/fimmu.2023.1261010.
[44]
Cao JJ, Ji LL, Zhan YX, et al. MST4 kinase regulates immune thrombocytopenia by phosphorylating STAT1-mediated M1 polarization of macrophages[J]. Cell Mol Immunol, 2023, 20(12): 1413-1427. DOI: 10.1038/s41423-023-01089-8.
[45]
Chen YL, Wang T, Liang FX, et al. Nicotinamide phosphoribosyl transferase prompts bleomycin-induced pulmonary fibrosis by driving macrophage M2 polarization in mice[J]. Theranostics, 2024, 14(7): 2794-2815. DOI: 10.7150/thno.94482.
[46]
Fu H, Zhang P, Zhao XD, et al. Interfering with Rac1-activation during neonatal monocyte-macrophage differentiation influences the inflammatory responses of M1 macrophages[J]. Cell Death Dis, 2023, 14(9): 619. DOI: 10.1038/s41419-023-06150-y.
[47]
Ma Y, Zhang YF, Liu XL, et al. Deletion of CD38 mitigates the severity of NEC in experimental settings by modulating macrophage-mediated inflammation[J]. Redox Biol, 2024, 77: 103336. DOI: 10.1016/j.redox.2024.103336.
[48]
Xu C, Li S, Fulford TS, et al. Expansion of MAIT cells in the combined absence of NKT and γδT cells[J]. Mucosal Immunol, 2023, 16(4): 446-461. DOI: 10.1016/j.mucimm.2023.05.003.
[49]
Lv MF, Zhang ZL, Cui Y. Unconventional T cells in brain homeostasis, injury and neurodegeneration[J]. Front Immunol, 2023, 14: 1273459. DOI: 10.3389/fimmu.2023.1273459.
[50]
Mihi B, Gong QQ, Nolan LS, et al. Interleukin-22 signaling attenuates necrotizing enterocolitis by promoting epithelial cell regeneration[J]. Cell Rep Med, 2021, 2(6): 100320. DOI: 10.1016/j.xcrm.2021.100320.
[51]
Chen JR, Liu J, Cao XT. Functional and metabolic heterogeneity of dendritic cells in self-tolerance and autoimmunity[J]. Immunol Rev, 2025, 336(1): e70068. DOI: 10.1111/imr.70068.
[52]
Anderson DA, Ou F, Kim S, et al. Transition from cMyc to L-Myc during dendritic cell development coordinated by rising levels of IRF8[J]. J Exp Med, 2022, 219(2): e20211483. DOI: 10.1084/jem.20211483.
[53]
Lamubol J, Ohto N, Kuwahara H, et al. Lactiplantibacillus plantarum 22A-3-induced TGF-β1 secretion from intestinal epithelial cells stimulated CD103＋ DC and Foxp3＋ Treg differentiation and amelioration of colitis in mice[J]. Food Funct, 2021, 12(17): 8044-8055. DOI: 10.1039/d1fo00990g.
[54]
Ke B, Li CY, Li S, et al. Vitamin D3 alleviates intestinal injury in necrotizing enterocolitis and lipopolysaccharide-induced inflammatory response in dendritic cells in rats[J]. Turk J Med Sci, 2024, 54(5): 1165-1174. DOI: 10.55730/1300-0144.5895.
[55]
Zhu H, Lin Y, Liu YL. MiR34a increases inflammation and oxidative stress levels in patients with necrotizing enterocolitis by downregulating SIRT1 expression[J]. Mol Med Rep, 2021, 24(3): 664.DOI: 10.3892/mmr.2021.12303.
[56]
Yumoto T, Oami T, Liang Z, et al. Intestinal epithelial-specific occludin deletion worsens gut permeability and survival following sepsis[J]. Shock, 2025, 63(4): 597-605. DOI: 10.1097/SHK.0000000000002531.
[57]
Biouss G, Antounians L, Li B, et al. Experimental necrotizing enterocolitis induces neuroinflammation in the neonatal brain[J]. J Neuroinflammation, 2019, 16(1): 97. DOI: 10.1186/s12974-019-1481-9.
[58]
Seo YM, Lin YK, Im SA, et al. Interleukin 8 may predict surgical necrotizing enterocolitis in infants born less than 1 500 g[J]. Cytokine, 2021, 137: 155343. DOI: 10.1016/j.cyto.2020.155343.
[59]
Yan XL, Liu XC, Zhang YN, et al. Succinate aggravates intestinal injury in mice with necrotizing enterocolitis[J]. Front Cell Infect Microbiol, 2022, 12: 1064462. DOI: 10.3389/fcimb.2022.1064462.
[60]
Cho SX, Berger PJ, Nold-Petry CA, et al. The immunological landscape in necrotising enterocolitis[J]. Expert Rev Mol Med, 2016, 18: e12. DOI: 10.1017/erm.2016.13.
[61]
Zhang YF, Yan M, Xia YY, et al. Glutaredoxin-1 modulates the NF-κB signaling pathway to activate inducible nitric oxide synthase in experimental necrotizing enterocolitis[J]. Mol Ther Methods Clin Dev, 2024, 32(1): 101214. DOI: 10.1016/j.omtm.2024.101214.
[62]
Kalkan AE, BinMowyna MN, Raposo A, et al. Beyond the gut: unveiling butyrate′s global health impact through gut health and dysbiosis-related conditions: a narrative review[J]. Nutrients, 2025, 17(8): 1305. DOI: 10.3390/nu17081305.
[63]
Ma ZY, Wang ZX, Cao J, et al. Regulatory roles of intestinal CD4＋ T cells in inflammation and their modulation by the intestinal microbiota[J]. Gut microbes, 2025, 17(1): 2560019. DOI: 10.1080/19490976.2025.2560019.
[64]
Verhasselt V. A newborn′s perspective on immune responses to food[J]. Immunol Rev, 2024, 326(1): 117-129. DOI: 10.1111/imr.13376.
[65]
Rio-Aige K, Fernández-Bargalló A, Vegas-Lozano E, et al. Breast milk immune composition varies during the transition stage of lactation: characterization of immunotypes in the MAMI cohort[J]. Front Nutr, 2023, 10: 1252815. DOI: 10.3389/fnut.2023.1252815.
[66]
Masi AC, Embleton ND, Lamb CA, et al. Human milk oligosaccharide DSLNT and gut microbiome in preterm infants predicts necrotising enterocolitis[J]. Gut, 2021, 70(12): 2273-2282. DOI: 10.1136/gutjnl-2020-322771.
[67]
Cristóbal-Cañadas D, Parrón-Carrillo R, Parrón-Carreño T. Exosomes in breast milk：their impact on the intestinal microbiota of the newborn and therapeutic perspectives for high-risk neonates[J]. Int J Mol Sci, 2025, 26(7): 3421. DOI: 10.3390/ijms26073421.
[68]
Sharif S, Meader N, Oddie SJ, et al. Probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants[J]. Cochrane Database Syst Rev, 2023, 7(7): CD005496. DOI: 10.1002/14651858.CD005496.pub6.
[69]
Chi C, Li C, Buys N, et al. Effects of probiotics in preterm infants: a network Meta-analysis[J]. Pediatrics, 2021, 147(1): e20200706. DOI: 10.1542/peds.2020-0706.
[70]
Dai Y, Yu QL, Zhang F, et al. Effect of probiotics on necrotizing enterocolitis in preterm infants：a network Meta-analysis of randomized controlled trials[J]. BMC Pediatrics, 2025, 25(1): 237. DOI: 10.1186/s12887-025-05469-z.
[71]
Rahkola EN, Rautava S, Hiltunen H, et al. The preterm gut microbiota and administration routes of different probiotics：a randomized controlled trial[J]. Pediatr Res, 2023, 94(4): 1480-1487. DOI: 10.1038/s41390-023-02560-y.
[72]
Aveline A, Szatkowski L, Berrington J, et al. Evaluating the effect of probiotics on severe necrotising enterocolitis in preterm infants born before 32 weeks gestation in England and Wales: a propensity-matched population study[J]. Lancet Reg Health Eur, 2026, 62: 101571. DOI: 10.1016/j.lanepe.2025.101571.
[73]
Huang YB, Niu WF, He YB, et al. Flash nano-encapsulation of probiotics：bolstering environmental resistance and intestinal colonization to prevent necrotizing enterocolitis[J]. J Control Release, 2025, 389: 114481. DOI: 10.1016/j.jconrel.2025.114481.
[74]
Meyer MB, Lee SM, Cichanski SR, et al. Spatial detection and consequences of nonrenal calcitriol production as assessed by targeted mass spectrometry imaging[J]. JCI Insight, 2024, 9(15): e181763. DOI: 10.1172/jci.insight.181763.
[75]
Lee PC, Hsieh YC, Huo TI, et al. Active vitamin D3 treatment attenuated bacterial translocation via improving intestinal barriers in cirrhotic rats[J]. Mol Nutr Food Res, 2021, 65(3): e2000937. DOI: 10.1002/mnfr.202000937.
[1] Hongyu Jiang, Jialuo Liang, Lin Ma, Yongqiang Deng, Xinghan Li. Current advances in biomarkers associated with immunotherapy in oral and oropharyngeal squamous cell carcinoma[J]. Chinese Journal of Stomatological Research(Electronic Edition), 2026, 20(02): 136-148.
[2] Junjie Li, Pei Dong, Cheng Yao, Ze Liu, Yong Li. Advances in immunotherapy for prostate cancer[J]. Chinese Journal of Endourology(Electronic Edition), 2026, 20(02): 209-215.
[3] Guineng Zeng, Penghui Yang, Rong Liu. Antitumor activity and immune activation effects of recombinant oncolytic influenza virus expressing IL-21 in pancreatic cancer[J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2026, 16(03): 129-139.
[4] Shengxiong Jia, Yan Xu, Xiaojun He, Kai Tan, Xilin Du. Regulation of CD47-SIRPα axis and CD47 targeted therapy: a new strategy to resolve drug resistance of immunotherapy for pancreatic cancer[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2026, 15(03): 337-345.
[5] Sijie Huang, Huiyong Zhang, Xiaohui Guo, Chengrun Xu. Prognostic value of systemic inflammatory response index in patients with advanced liver cancer after TACE combined with targeted immunotherapy[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2026, 15(03): 355-361.
[6] Yongqing Ye, Shuaimei Luo, Shunqian Wen, Junpeng Chen, Xianhua Zhang, Liyun Huang, Qijun Lao, Qing Wu. Progress in targeted immunotherapy for intermediate-advanced hepatocellular carcinoma[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2026, 15(03): 413-419.
[7] Rongdong He, ·Tuxun Tuerhongjiang, Hao Wen. Research progress in IL-23/IL-17 axis in echinococcosis[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2026, 15(03): 426-432.
[8] Linsen Ye, Yang Yang. Challenges and explorations of advanced liver cancer treatment: review and prospect[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2026, 15(03): 290-298.
[9] Zheng Zhou, Shuai Hu, Maoyun Xie, Xiyan Zheng, Ting Liu, Zhiqun Lin, Xianqing Chen, Fei Du, Xianjie Shi. Research progress in perioperative adjuvant therapy for resectable hepatocellular carcinoma[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2026, 15(03): 317-325.
[10] Wei Xie, Xiaofeng Zhang, Feng Shen. Eepidemiological characteristics, mechanism, prevention and treatment strategies of immune-related adverse events from tumor immunotherapy[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2026, 15(02): 146-151.
[11] Chen Wang, Fang Xu, Fang Zhou, Jin Liu, Fang Sheng. Effect of fatty liver disease on clinical efficacy and prognosis of systemic treatment for advanced ICC[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2026, 15(02): 226-233.
[12] Jing Zhao, Danling He, Shengjie Hong, Guangquan Zhang, Hanxi He. Prevention and treatment of immune-related skin complications from targeted therapy and immunotherapy for hepatocellular carcinoma[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2026, 15(02): 266-270.
[13] Pengfei Yin, Kun Wu, Huaizhi Wang, Lei Cai. Advances in immunotherapy strategy for hepatocellular carcinoma and its application in perioperative period[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2026, 15(01): 21-27.
[14] Xiumei Chen, Manying Xie, Sijuan Chen, Xuhui Zhong, Qiao Pan, Lijuan Wen, Expert Consensus Writing Group. Expert consensus on nursing management of immune-related adverse events in patients with advanced non-small cell lung cancer[J]. Chinese Journal of Clinicians(Electronic Edition), 2026, 20(02): 77-89.
[15] Xuelian Liu, Dan Zhu, Zhangmei Huang, Weijie Tian, Xian Fu. Qualitative Study on Symptom Experience in Patients with Primary Liver Cancer Undergoing TACE Combined with Targeted and Immunotherapy[J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2026, 14(01): 40-45.
Viewed
Full text


Abstract

Copyright © Chinese Medical Association, Chinese Medical Multimedia Press  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号